Phosphoglycerate dehydrogenase (PHGDH), the enzyme that catalyzes the first step in the serine–glycine biosynthesis pathway, is amplified in human melanoma and ER-negative breast cancer (3, 4). This evidence concerns the gene PHGDH and melanoma.